A predictive model to guide management of the overlap region between target volume and organs at risk in prostate cancer volumetric modulated arc therapy |
Mattes, Malcolm D.
(Department of Radiation Oncology, New York Methodist Hospital)
Lee, Jennifer C. (Department of Radiation Oncology, New York Methodist Hospital) Elnaiem, Sara (Department of Radiation Oncology, New York Methodist Hospital) Guirguis, Adel (Department of Radiation Oncology, New York Methodist Hospital) Ikoro, N.C. (Department of Radiation Oncology, New York Methodist Hospital) Ashamalla, Hani (Department of Radiation Oncology, New York Methodist Hospital) |
1 | Hunt MA, Jackson A, Narayana A, Lee N. Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. Int J Radiat Oncol Biol Phys 2006;66:296-304. DOI |
2 | Vineberg KA, Eisbruch A, Coselmon MM, McShan DL, Kessler ML, Fraass BA. Is uniform target dose possible in IMRT plans in the head and neck? Int J Radiat Oncol Biol Phys 2002;52:1159-72. DOI |
3 | Wu B, Ricchetti F, Sanguineti G, et al. Patient geometry-driven information retrieval for IMRT treatment plan quality control. Med Phys 2009;36:5497-505. DOI |
4 | Wu B, McNutt T, Zahurak M, et al. Fully automated simultaneous integrated boosted-intensity modulated radiation therapy treatment planning is feasible for head-and-neck cancer: a prospective clinical study. Int J Radiat Oncol Biol Phys 2012;84:e647-53. DOI |
5 | Cheung MR, Tucker SL, Dong L, et al. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2007;67:1059-65. DOI |
6 | Gauthier I, Carrier JF, Beliveau-Nadeau D, Fortin B, Taussky D. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose escalated prostate cancer radiation treatment. Int J Radiat Oncol Biol Phys 2009;74:1128-33. DOI |
7 | Azcona JD, Li R, Mok E, Hancock S, Xing L. Automatic prostate tracking and motion assessment in volumetric modulated arc therapy with an electronic portal imaging device. Int J Radiat Oncol Biol Phys 2013;86:762-8. DOI |
8 | Das S, Liu T, Jani AB, et al. Comparison of image-guided radiotherapy technologies for prostate cancer. Am J Clin Oncol 2013 Feb 20 [Epub]. http://dx.doi.org/10.1097/COC.0b013e31827e4eb9. |
9 | Yang Y, Ford EC, Wu B, et al. An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection. Med Phys 2013;40:011709. DOI |
10 | Susil RC, McNutt TR, DeWeese TL, Song D. Effects of prostaterectum separation on rectal dose from external beam radiotherapy. Int J Radiat Oncol Biol Phys 2010;76:1251-8. DOI |
11 | Pinkawa M, Corral NE, Caffaro M, et al. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer. Radiother Oncol 2011;100:436-41. DOI |
12 | Mohan R, Wang X, Jackson A, et al. The potential and limitations of the inverse radiotherapy technique. Radiother Oncol 1994;32:232-48. DOI ScienceOn |
13 | Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S10-9. DOI ScienceOn |
14 | Breitman K, Rathee S, Newcomb C, et al. Experimental validation of the Eclipse AAA algorithm. J Appl Clin Med Phys 2007;8:76-92. |
15 | Rodgers JL, Nicewander AW. Thirteen ways to look at the correlation coefficient. Am Stat 1988;42:59-66. |
16 | Goulet CC, Herman MG, Hillman DW, Davis BJ. Estimated limits of IMRT dose escalation using varied planning target volume margins. Phys Med Biol 2008;53:3777-88. DOI |
17 | Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 2000;89:1800-9. DOI ScienceOn |
18 | Kassim I, Dirkx ML, Heijmen BJ. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients. Radiother Oncol 2009;92:62-7. DOI |
19 | Zelefsky MJ, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000;55:241-9. DOI ScienceOn |
20 | Zhu X, Ge Y, Li T, Thongphiew D, Yin FF, Wu QJ. A planning quality evaluation tool for prostate adaptive IMRT based on machine learning. Med Phys 2011;38:719-26. DOI |
21 | Appenzoller LM, Michalski JM, Thorstad WL, Mutic S, Moore KL. Predicting dose-volume histograms for organs-at-risk in IMRT planning. Med Phys 2012;39:7446-61. DOI |
22 | Moore KL, Brame RS, Low DA, Mutic S. Experience-based quality control of clinical intensity-modulated radiotherapy planning. Int J Radiat Oncol Biol Phys 2011;81:545-51. DOI |
23 | De Meerleer GO, Vakaet LA, De Gersem WR, De Wagter C, De Naeyer B, De Neve W. Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. Int J Radiat Oncol Biol Phys 2000;47:639-48. DOI ScienceOn |
24 | Zelefsky MJ, Harrison A. Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: reducing the potential morbidity of therapy. Urology 1997;49(3A Suppl):38-45. DOI |
25 | Corletto D, Iori M, Paiusco M, et al. Inverse and forward optimization of one- and two-dimensional intensitymodulated radiation therapy-based treatment of concaveshaped planning target volumes: the case of prostate cancer. Radiother Oncol 2003;66:185-95. DOI ScienceOn |
26 | Damen EM, Brugmans MJ, van der Horst A, et al. Planning, computer optimization, and dosimetric verification of a segmented irradiation technique for prostate cancer. Int J Radiat Oncol Biol Phys 2001;49:1183-95. DOI |
27 | Wolff D, Stieler F, Welzel G, et al. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. Radiother Oncol 2009;93:226-33. DOI ScienceOn |
28 | Cozzi L, Dinshaw KA, Shrivastava SK, et al. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol 2008;89:180-91. DOI ScienceOn |
29 | Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO. Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S123-9. DOI |
30 | Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994;271:368-74. DOI ScienceOn |